EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genomic and transcriptomic quality control for an autologous iPSC-derived cell therapy for Parkinson’s disease

Andres M Bratt-Leal, Thorsten Gorba, Roy M Williams, Jim A Mossman, Rachel Hills, Ha Tran, Derren Barken, Genevieve Beauvais, Daniel Fremgen, Ai Zhang, Cullen Pivaroff, Candace Lynch und 12 weitere

Cell Stem Cell · 2026

DOI: 10.1016/j.stem.2026.08.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Stem Cell, 2026. Verfasst von Andres M Bratt-Leal und 23 weiteren Autor:innen. Beteiligte Einrichtung: Aspen Neuroscience, San Diego, CA, USA. Electronic address: abrattleal@aspenneuro.com. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Parkinson Disease, Transcriptome, Genomics. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: California Institute for Regenerative Medicine, Aspen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Induced Pluripotent Stem CellsParkinson DiseaseTranscriptomeGenomicsCell- and Tissue-Based TherapyHumansAnimalsQuality ControlDopaminergic NeuronsTransplantation, AutologousCell Differentiation

Stichwörter der Autor:innen

Parkinson’s diseaseautologouscell therapyclinical trialdopaminergic neuronsgenomicsinduced pluripotent stem cellspreclinicalregenerative medicinetransplantation

Autor:innen und Institutionen

  • Aspen Neuroscience, San Diego, CA, USA. Electronic address: abrattleal@aspenneuro.com.
  • Aspen Neuroscience, San Diego, CA, USA.
  • Brain Repair Group, School of Biosciences, Cardiff University, Cardiff, UK.
  • Scripps Research Institute, La Jolla, CA, USA.

Förderung

  • California Institute for Regenerative Medicine
  • Aspen

Zitieren

APA

Bratt-Leal, A. M., Gorba, T., Williams, R. M., Mossman, J. A., Hills, R., Tran, H., Barken, D., Beauvais, G., Fremgen, D., Zhang, A., Pivaroff, C., Lynch, C., Liu, Y., Chandrasekaran, C., Tastad, D., Bridge, C., Wakeman, D. R., Nguyen, U., Chamberlain, B., …, & Zhang, X. (2026). Genomic and transcriptomic quality control for an autologous iPSC-derived cell therapy for Parkinson’s disease. Cell Stem Cell. https://doi.org/10.1016/j.stem.2026.08.014

Vancouver

Bratt-Leal AM, Gorba T, Williams RM, Mossman JA, Hills R, Tran H, et al. Genomic and transcriptomic quality control for an autologous iPSC-derived cell therapy for Parkinson’s disease. Cell Stem Cell. 2026. doi:10.1016/j.stem.2026.08.014

BibTeX
@article{BrattLeal2026,
  author = {Bratt-Leal, Andres M and Gorba, Thorsten and Williams, Roy M and Mossman, Jim A and Hills, Rachel and Tran, Ha and Barken, Derren and Beauvais, Genevieve and Fremgen, Daniel and Zhang, Ai and Pivaroff, Cullen and Lynch, Candace and Liu, Yanzheng and Chandrasekaran, Chandnee and Tastad, David and Bridge, Charlotte and Wakeman, Dustin R and Nguyen, Uyen and Chamberlain, Brent and Lane, Emma L and Lelos, Mariah J and Loring, Jeanne F and Wirth, Edward D and Zhang, Xiaokui},
  title = {Genomic and transcriptomic quality control for an autologous iPSC-derived cell therapy for Parkinson’s disease},
  journal = {Cell Stem Cell},
  year = {2026},
  doi = {10.1016/j.stem.2026.08.014}
}
Kostenlos starten →